APLLTD Intraday Analysis...

APLLTD Share Price

Open 453.65 Change Price %
High 463.80 1 Day -20.75 -4.46
Low 439.95 1 Week -40.00 -8.26
Close 444.55 1 Month -55.90 -11.17
Volume 43554 1 Year -155.80 -25.95
52 Week High 610.00
52 Week Low 439.95
APLLTD Important Levels
Resistance 2 466.66
Resistance 1 457.55
Pivot 449.43
Support 1 431.55
Support 2 422.44
NSE INDIA Most Active Stocks
RCOM 13.35 -12.75%
JPASSOCIAT 14.20 -18.62%
ASHOKLEY 134.30 -9.50%
PNB 78.15 4.55%
RNAVAL 14.40 -6.49%
ICICIBANK 289.30 1.12%
SUZLON 8.70 -1.69%
GMRINFRA 17.00 -2.02%
SBIN 244.45 2.34%
STAR 341.00 -11.90%
More..
NSE INDIA Top Gainers Stocks
GREENFIRE 0.15 50.00%
UVSL 0.20 33.33%
DWARKESH 23.45 12.20%
SFL 1451.00 11.66%
SFL 1451.00 11.66%
SFL 1451.00 11.66%
REPRO 676.65 9.16%
DHAMPURSUG 93.05 8.89%
UTTAMSUGAR 86.00 8.04%
INDSWFTLAB 66.05 7.22%
More..
NSE INDIA Top Losers Stocks
NAKODA 0.15 -25.00%
KITEX 182.20 -19.36%
JPASSOCIAT 14.20 -18.62%
GMBREW 855.35 -16.73%
SPYL 0.25 -16.67%
MVL 0.25 -16.67%
MVL 0.25 -16.67%
SHIVATEX 387.80 -15.59%
IMFA 368.20 -14.54%
NACLIND 31.00 -14.48%
More..

Alembic Pharmaceuticals Limited (NSE: APLLTD)

APLLTD Technical Analysis 5
As on 21st May 2018 APLLTD Share Price closed @ 444.55 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 523.17 & Strong Sell for SHORT-TERM with Stoploss of 522.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
APLLTD Target for May
1st Target up-side 574.63
2nd Target up-side 603.07
3rd Target up-side 631.51
1st Target down-side 493.47
2nd Target down-side 465.03
3rd Target down-side 436.59
APLLTD Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is Below 20 Over Sold
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 500.45
10 Day Avg Volume Traded 49.07 % More then 10 Day Average Volume
APLLTD Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
APLLTD Address
APLLTD
N/A
APLLTD Latest News
Alembic Pharma - Q3 results on Feb 04, 2015   Moneycontrol.com   - 23rd Jan 15
Alembic Pharma buying 49% stake in Algerian drugmaker Adwiya Mami   VC Circle   - 27th Oct 14
Alembic Pharma, Hester Biosciences net profit jumps 25%, 66% respectively   Economic Times   - 21st Oct 14
Alembic Pharma Q2 net up 54%   Business Standard   - 25th Oct 13
Alembic Pharma's net profit 27 pc up; to abandon low margin API & formulation   Economic Times   - 02nd May 13
Alembic Pharma to focus on regulated markets   Business Standard   - 21st Jan 13
Alembic Pharma will add more specialty product, Q2 net profit up 12%   Economic Times   - 19th Oct 12
Alembic Pharma - Fire at API 1 plant at Panelav, Gujarat   Moneycontrol.com   - 27th Aug 12
Alembic Pharma   Moneycontrol.com   - 20th Sep 11
Alembic Pharma sales up 34%, plans Brazil foray   Economic Times   - 27th Jul 11
Interactive Technical Analysis Chart Alembic Pharmaceuticals Limited ( APLLTD NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Alembic Pharmaceuticals Limited
APLLTD Business Profile
Alembic Pharma is in the Pharmaceuticals sector. It is established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara. The current market capitalisation stands at Rs 3,760.89 crore.The company has reported a consolidated sales of Rs 484.28 crore and a Net Profit of Rs 61.64 crore for the quarter ended Sep 2013. The company management includes Chirayu R Amin - Chairman & Managing Director, K G Ramanathan - Director, Paresh Saraiya - Director, Pranav N Parikh - Director, Milin Mehta - Director, Pranav Amin - President & Director, Shaunak Amin - President & Director, R K Baheti - Dir-President & Com.Secretary. It is listed on the BSE with a BSE Code of 533573 and the NSE with an NSE Code of APLLTD. Its Head office is at Alembic Road , Vadodra,Gujarat - 390003.